Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,002
Closed -$4.89M 158
2025
Q4
$4.89M Sell
75,002
-21,175
-22% -$1.69M 1.26% 23
2025
Q3
$7.9M Buy
96,177
+60,463
+169% +$4.35M 1.94% 9
2025
Q2
$2.35M Sell
35,714
-11,782
-25% -$733K 0.86% 30
2025
Q1
$3.12M Buy
47,496
+3,692
+8% +$250K 1.2% 10
2024
Q4
$3.36M Sell
43,804
-11,335
-21% -$979K 1.25% 16
2024
Q3
$4.6M Buy
55,139
+4,099
+8% +$273K 1.59% 4
2024
Q2
$2.82M Sell
51,040
-21,190
-29% -$1.15M 1.03% 23
2024
Q1
$5.02M Hold
72,230
1.79% 6
2023
Q4
$4.01M Sell
72,230
-5,798
-7% -$262K 1.45% 15
2023
Q3
$2.8M Buy
78,028
+15,159
+24% +$523K 1.3% 21
2023
Q2
$1.99M Buy
62,869
+8,589
+16% +$328K 0.91% 33
2023
Q1
$1.67M Buy
+54,280
New +$1.65M 1.36% 27

Other funds holding ACLX

HighVista Strategies's ACLX Position: Q1 2026 in Review

HighVista Strategies sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 75,002 shares — an estimated $4.89M sold.

HighVista Strategies first reported a position in ACLX in Q1 2023 and held it in 12 quarters. The position peaked at $7.9M in Q3 2025. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • HighVista Strategies reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • HighVista Strategies sold 75,002 Arcellx shares in Q1 2026, an estimated $4.89M.
  • HighVista Strategies first reported a position in Arcellx in Q1 2023 and held it in 12 quarters.
  • HighVista Strategies's Arcellx position peaked at $7.9M in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.